Martin Glen

Martin Glen is an Investment Director at Parkwalk Advisors, where they manage investments in UK university spinouts for EIS clients. Martin has amassed extensive experience in finance, previously serving as an analyst at Lehman Brothers and Lazard Capital Markets, and managing the deal desk at Meditor. Currently, Martin holds directorships at several companies including GripAble, Psyomics Ltd, M-Spin, Cytora, and Wayland Additive, while also having a non-executive director role at Charco Neurotech. With a strong educational background in Chemistry from St. Edmund Hall, Oxford University, Martin continues to engage with innovative technology ventures.